摘要
BACKGROUND The coronavirus disease 2019(COVID-19)pandemic has posed obstacles to the delivery of diabetic foot care.In response to this remote healthcare services have been deployed offering monitoring,follow-up,and referral services to patients with diabetic foot ulcers and related conditions.Although,remote diabetic foot care has been studied before the COVID-19 pandemic as an alternative to inperson care,the peculiar situation of the pandemic,which dictates that remote care would be the sole available option for healthcare practitioners and patients,necessitates an evaluation of the relevant knowledge obtained since the beginning of the severe acute respiratory syndrome coronavirus 2 outbreak.AIM To perform a thorough search in PubMed/Medline and Cochrane to identify original records on the topic.METHODS To identify relevant peer-reviewed publications and gray literature,the authors searched PubMed-MEDLINE and Cochrane Library-Cochrane Central Register of Controlled Trials starting September 27 till October 31,2021.The reference lists of the selected sources and relevant systematic reviews were also hand–searched to identify potentially relevant resources.Otherwise,the authors searched Reference Citation Analysis(https://www.referencecitationanalysis.com/).RESULTS A number of randomized prospective studies,case series,and case reports have shown that the effectiveness of remote care is comparable to in-person care in terms of hospitalizations,amputations,and mortality.The level of satisfaction of patients’receiving this type of care was high.The cost of remote healthcare was not significantly lower than in-person care though.CONCLUSION It is noteworthy that remote care during the COVID-19 pandemic appeared to be more effective and well-received than remote care in the past.Nevertheless,larger studies spanning over longer time intervals are necessary in order to validate these results and provide additional insights.
